Results 171 to 180 of about 2,622 (185)

The Relative Bioavailability and Effects of Food and Acid‐Reducing Agents on Filgotinib Tablets in Healthy Subjects

Clinical Pharmacology in Drug Development, 2019
Shringi Sharma, Ann Ran-Ran Qin, Florence Namour   +2 more
exaly  

Validated LC–MS/MS method for quantitation of a selective JAK1 inhibitor, filgotinib in rat plasma, and its application to a pharmacokinetic study in rats

Biomedical Chromatography, 2020
Vinay Kiran, Ramesh Mullangi
exaly  

Rheumatoide Arthritis: Filgotinib mit gutem Sicherheitsprofil

Orthopädie & Rheuma, 2021
openaire   +1 more source

Filgotinib/upadacitinib

Reactions Weekly
openaire   +1 more source

Filgotinib/tofacitinib/upadacitinib

Reactions Weekly
openaire   +2 more sources

Filgotinib/Tofacitinib

Reactions Weekly
openaire   +1 more source

Filgotinib/tacrolimus

Reactions Weekly
openaire   +1 more source

Baricitinib/Filgotinib

Reactions Weekly
openaire   +1 more source

Filgotinib for Crohn's disease—expanding treatment options

The Lancet, 2017
openaire   +2 more sources

AB0667 THE EFFICACY OF FILGOTINIB IN RHEUMATOID ARTHRITIS MAY BE TIME-DEPENDENT. (IN VIEW OF THE HILL COEFFICIENT OF FILGOTINIB)

Annals of the Rheumatic Diseases
T. Yoshikawa, T. Abe, M. Tamura, T. Furukawa, T. Hashimoto, N. Azuma, K. Matsui   +6 more
openaire   +1 more source